KURA logo
Kura Oncology, Inc.(KURA)
Last print unknown agoAbout this dataData status
$9.36▲0.28 (3.08%)Stale · unknown oldEarnings · Nov 3

KURA Operating Cash Flow (Statement)

-$111.76MTTM · USD

Period ending:

KURA FY Cash from OperationsUSD
KURA FY Cash from Operations2008-12-31: -$31.77K2009-12-31: -$21.37K2010-12-31: -$19.24K2011-12-31: -$19.24K2012-12-31: -$22.68K2013-12-31: -$24.42K2014-12-31: -$2.55K2015-12-31: -$17.93M2016-12-31: -$25.35M2017-12-31: -$28.44M2018-12-31: -$48.66M2019-12-31: -$54.76M2020-12-31: -$69.83M2021-12-31: -$104.55M2022-12-31: -$110.06M2023-12-31: -$124.82M2024-12-31: $134.32M2025-12-31: -$64.06M$134.32M-$124.82M
2008-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

KURA operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 18 observations from Dec 31, 2008 to Dec 31, 2025.

Kura Oncology Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-64,058,000
134,317,000
-124,824,000
-110,062,000
-104,551,000
-69,830,000
-54,760,000
-48,655,000
-28,441,000
-25,349,000
-17,925,000
-2,547
-24,418
-22,678
-19,244
-19,244
-21,366
-31,765

Compare operating cash flow (statement)

All KURA financial metrics · KURA stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.